Amplitude Healthcare Acquisition Corporation (AMHC) to Combine with Jasper Therapeutics in $290M Deal

Amplitude Healthcare Acquisition Corporation (AMHC) to Combine with Jasper Therapeutics in $290M Deal

Amplitude Healthcare (NASDAQ:AMHC) has entered into a definitive agreement to combine with hematopoietic cell transplant firm Jasper Therapeutics at an enterprise value of $290 million. Biotechnology firm Jasper is working to cure several life threatening diseases such as blood cancers, sickle cell, and autoimmune disorders in underserved patients including infants, women, and minorities. The Palo-Alto
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.